Gossamer Bio, Inc. (GOSS) vs XBiotech Inc. (XBIT)
A side-by-side comparison of Gossamer Bio, Inc. and XBiotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GOSS
Gossamer Bio, Inc.
$10.55HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
XBIT
XBiotech Inc.
$2.18HealthcareDelayed quote: Oct 6, 2026, 1:21 PM EDT
Total return — GOSS vs XBIT
growth of $100 · dividends reinvested · last 8yGOSS -99.3% (-45.8%/yr)XBIT -74.6% (-15.7%/yr)XBIT compounded faster over this window
Log scale — wide-divergence pair
GOSS XBIT
GOSS vs XBIT: by the numbers
- •XBIT is the larger company ($66M vs $64M market cap).
- •Both run net losses; XBIT's is the smaller (0.00% vs -235.00% net margin).
Metrics side by side
Valuation
| Metric | GOSS | XBIT |
|---|---|---|
| P/S ratio | 1.21 | N/A |
| P/B ratio | N/A | 0.52 |
Profitability
| Metric | GOSS | XBIT |
|---|---|---|
| Gross margin | 99.56% | 0.00% |
| Operating margin | -336.81% | 0.00% |
| Net margin | -235.00% | 0.00% |
| ROE | N/A | -35.13% |
| ROIC | N/A | -37.01% |
Growth (annualized)
| Metric | GOSS | XBIT |
|---|---|---|
| Total return CAGR (5Y) | -59.51% | -29.36% |
Frequently asked
- How have GOSS and XBIT total returns compared?
- Over the past 5 years, GOSS delivered -59.51% and XBIT delivered -29.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.